Children’s Robitussin and Dimetapp Recalled

MONDAY, June 22, 2020 — Two loads of Children’s Robitussin Honey Cough and Chest Congestion DM and 1 lot of Children’s Dimetapp Chilly and Cough have been recalled mainly because they have incorrect dosing cups that could put children at hazard of an overdose. The dosing cups for Children’s Robitussin […]

Two lots of Children's Robitussin Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp Cold and Cough have been recalled because they have incorrect dosing cups that could put children at risk of an overdose.

MONDAY, June 22, 2020 — Two loads of Children’s Robitussin Honey Cough and Chest Congestion DM and 1 lot of Children’s Dimetapp Chilly and Cough have been recalled mainly because they have incorrect dosing cups that could put children at hazard of an overdose.

The dosing cups for Children’s Robitussin Honey are missing the 5 mL and 10 mL graduations, although the dosing cups for the Children’s Dimetapp are missing the 10 mL graduation. The dosing cups with both of those products only have the 20 mL graduation, in accordance to GSK Consumer Health care.

There is a hazard of an accidental overdose if grown ups dispensing the products never detect the discrepancies in between the graduations printed on the dosing cups and the label’s indicated amounts to be presented to children, the business warned.

The recall is for: Children’s Robitussin Honey Cough and Chest Congestion DM (4oz)NDC 0031-8760-12, Tons: 02177 (Exp. Jan. 2022), 02178 (Exp. Jan. 2022) and Children’s Dimetapp Chilly and Cough (8oz), NDC 0031-2234-19, Great deal: CL8292 (Exp. Sep. 2021).

The loads were distributed across the United States in between Feb, 5, 2020, and June three, 2020.

For more information, buyers can call 1-800-762-4675, Monday to Friday, 8 am to six pm EST.

MedicalNews
Copyright © 2020 HealthDay. All legal rights reserved.




Query

The abbreviated term ADHD denotes the ailment typically recognised as:
See Respond to

Next Post

Citing Lack of Benefit, NIH Halts Trial of Hydroxychloroquine for COVID-19

By E.J. MundellHealthDay Reporter MONDAY, June 22, 2020 (HealthDay News) — The U.S. Countrywide Institutes of Heath declared Saturday that it was stopping a scientific demo of hydroxychloroquine, a drug lengthy supported by President Donald Trump as a probable panacea for COVID-19. “A knowledge and protection monitoring board satisfied late […]

Subscribe US Now